Results 131 to 140 of about 145,714 (241)

Comparable outcomes among etiologies in early‐stage hepatocellular carcinoma: Analysis of a nationwide registry in Japan

Hepatology Research, Volume 55, Issue 4, Page 556-566, April 2025.
A nationwide registry named REAL has been developed to collect data on the initial diagnosis, each admission for recurrent disease, and prognosis of primary liver cancer and decompensated liver cirrhosis in Japan. The current study revealed that the prognosis of patients with liver cancer was similar among different etiologies. Abstract Aim Tumor stage
Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa, Hisateru Tachimori, Koji Uchino, Ryo Nakagomi, Tomoharu Yamada, Takuma Nakatsuka, Tatsuya Minami, Masaya Sato, Mitsuhiro Fujishiro, Kiyoshi Hasegawa, Yuichiro Eguchi, Tatsuya Kanto, Hitoshi Yoshiji, Namiki Izumi, Masatoshi Kudo, Kazuhiko Koike   +17 more
wiley   +1 more source

Effects of sodium/glucose cotransporter 2 inhibitors on the coagulation profile in patients with coronary-artery disease and type 2 diabetes mellitus: a retrospective cohort study. [PDF]

Front Cardiovasc Med
Qin X, Song G.
europepmc   +1 more source

Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation [PDF]

, 2001
Calatzis, A., Schiffl, Helmut, Schramm, W., Spannagl, M., Toepfer, Marcel   +4 more
core   +1 more source

Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct‐acting antivirals

Hepatology Research, Volume 55, Issue 5, Page 631-637, May 2025.
Direct‐acting antiviral treatment for patients with type C liver cirrhosis not only improves the liver function, but also reduces the myostatin level, which is associated with muscle atrophy. Therefore, antiviral therapy may improve sarcopenia associated with chronic liver disease.
Tomoyuki Suehiro, Hideko Kozuru, Kosuke Matusmoto, Yuki Kugiyama, Yasuhide Motoyoshi, Akira Saeki, Shinya Nagaoka, Kazumi Yamasaki, Atsumasa Komori, Hiroshi Yatsuhashi   +9 more
wiley   +1 more source

Serious issues with cryo-EM structures of human prothrombinase. [PDF]

Open Biol
Huntington JA, Faille A, Ustok FI.
europepmc   +1 more source

Pancreatic congestion is associated with exocrine pancreatic function in liver cirrhosis

Hepatology Research, Volume 55, Issue 5, Page 685-695, May 2025.
Abstract Aim Portal hypertension resulting from liver cirrhosis (LC) can lead to pancreatic congestion and impaired insulin secretion. Therefore, this prospective study aimed to assess the association between pancreatic congestion and exocrine pancreatic function in patients with LC.
Masahito Kokubu, Yoshiki Imamura, Teru Kumagi, Masashi Hirooka, Yuki Numata, Yusuke Okujima, Sho Ishikawa, Kaori Marui‐Sato, Mitsuhito Koizumi, Yoichi Hiasa   +9 more
wiley   +1 more source

The Development of a Nomogram Predictive Model for Intracardiac Thrombosis Risk: A Study Based on Risk Factors in Patients with Acute Myocardial Infarction. [PDF]

Biomedicines
Huo X, Lian Z, Dang P, Zhang Y.
europepmc   +1 more source

Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis

Hepatology Research, EarlyView.
Durvalumab plus tremelimumab (Dur/Tre) therapy is expected to have good therapeutic efficacy for patients with unresectable hepatocellular carcinoma (u‐HCC). We revealed that the neutrophil‐to‐lymphocyte ratio at the start of the second course (NLR‐2c) value is useful for predicting PFS in u‐HCC patients treated with Dur/Tre therapy.
Takanori Suzuki, Kentaro Matsuura, Satoshi Sobue, Daisuke Kato, Katsumi Hayashi, Hiromu Kondo, Kaiki Anbe, Tsutomu Mizoshita, Kohei Okayama, Fumihiro Okumura, Yoshihide Kimura, Atsushi Ozasa, Hiroki Inada, Takayuki Tokunaga, Satoshi Narahara, Hayato Kawamura, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Yasuhito Tanaka   +19 more
wiley   +1 more source

Des-γ-carboxy Prothrombin in hepatocellular carcinoma post-operative recurrence risk evaluation. [PDF]

Commun Med (Lond)
Pan X, Zhou Y, Li Z, Guo P, Zeng J, Dong X, Hu E, Qiu L, Cai Z, Chen G, Liu X.   +10 more
europepmc   +1 more source

Nationwide survey of patients with acute liver failure and late‐onset hepatic failure in Japan seen between 2016 and 2021

Hepatology Research, EarlyView.
Abstract Aim A nationwide survey was conducted to clarify the recent status of patients with acute liver failure (ALF) and late‐onset fulminant hepatitis (LOHF) in Japan. Methods Two‐step surveys were performed annually targeting 782 hospitals, focusing on patients meeting the Japanese diagnostic criteria.
Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida, Akio Ido, Yasuhiro Takikawa, Keisuke Kakisaka, Naoya Kato, Kazuaki Chayama, Kazuaki Inoue, Mureo Kasahara, Shuji Terai, Hiromasa Ohira, Isao Sakaida, Taro Takami, Kiyoshi Hasegawa, Masanori Abe, Masahito Shimizu, Hitoshi Yoshiji, Takuya Genda, Ayano Inui, Ryuzo Abe, Hajime Takikawa, Atsushi Tanaka, Satoshi Mochida   +23 more
wiley   +1 more source